Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Malaysian palm oil price edges down on overnight soyoil losses

8h thestar.com.my
The benchmark palm oil contract for October delivery on the Bursa Malaysia Derivatives Exchange was down 0.1 percent at 2,171 ringgit ($536.78) a tonne at the end of the trading day, near a three-year low hit on Friday. Trading volume stood at 61,574 lots of 25 tonnes each.
SCGLF SCGLY GLE

0
Malaysian palm oil price snaps losing streak on improved demand

2018-07-16 thestar.com.my
The benchmark palm oil contract for October delivery on the Bursa Malaysia Derivatives Exchange was up 0.7 percent at 2,173 ringgit ($537.87) a tonne at the close of trade, its strongest daily gain in over two weeks. Trading volume stood at 48,843 lots of 25 tonnes each at the close of trade.
SCGLF SCGLY GLE

0
Resolute Mining secures US$100 million revolving loan facility from Investec

2018-07-13 proactiveinvestors.com.au
Resolute Mining Limited (ASX:RSG) has secured a US$100 million revolving loan facility from Investec Australia Limited.
RSG SCGLF RMGGY RMGGF SCGLY GLE

1
Meet the Traders Caught up in Euribor Trial - Bloomberg

2018-07-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
CRZBY BCS.PRD BCS BCS.PRC DB BCS.PRA SCGLY 83SF BCS.PR SCGLF 83SK CRZBF GLE 47MC

0
Former Barclays trader found guilty of rigging interest rate

2018-07-12 theedgemarkets
LONDON (July 12): A French former trader with Barclays, tried in his absence by a London court, has been convicted of helping to mastermind a five-year plot to rig global interest rates after an 11-week trial.
DB SCGLF SCGLY GLE

0
Easing risk in Ivory Coast banking sector a slow process - Moody's

2018-07-12 reuters
JOHANNESBURG, July 12 (Reuters) - Heavy exposure to a handful of borrowers has endangered the banking sector in regional financial hub Ivory Coast and reducing that risk will be a slow process despite reforms, a senior analyst with rating agency Moody’s said on Thursday.
SCGLF SCGLY GLE

0
Poland - Factors to Watch July 12

2018-07-12 reuters
Following are news stories, press reports and events that may affect Poland’s financial markets on Thursday. ALL TIMES GMT (Poland: GMT + 2 hours):
SCGLF SCGLY GLE

0
RPT-GRAPHIC-Five Charts: Where would a falling yuan hit hardest?

2018-07-12 reuters
LONDON, July 11 (Reuters) - China’s yuan suffered its biggest ever monthly drop in June, battered by worries that a deepening trade conflict with the United States will squeeze its economy and investors will pull out their money.
SCGLF SCGLY GLE

1
Crude crumbles under trade war that imperils economic growth

2018-07-11 malaymail
NEW YORK, July 12 — Crude plunged the most in two years as the escalating US-China trade war that threatens economic growth overshadowed the biggest drop in American crude inventories since 2016.
RDS.B RDS.A SCGLF RYDBF SCGLY RDSB GLE RDSA RYDAF

0
Trade War Kills Currency Volatility, Leaves Analysts Flummoxed - Bloomberg

2018-07-11 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
CRZBY SCGLF CRZBF SCGLY GLE

0
GRAPHIC-Platinum reels from speculative sell-off, persistent surplus

2018-07-11 reuters
LONDON (Reuters) - A surplus of platinum and demand concerns due to a dispute over global trade have fueled a sell-off that saw prices of the autocatalyst metal hit their lowest in a decade, below the cost of production for many mines in top producer South Africa.
SCGLF JMPLY SCGLY GLE JMPLF

0
GRAPHIC-Five Charts: Where would a falling yuan hit hardest?

2018-07-11 reuters
LONDON, July 11 (Reuters) - China’s yuan suffered its biggest ever monthly drop in June, battered by worries that a deepening trade conflict with the United States will squeeze its economy and investors will pull out their money.
SCGLF SCGLY GLE

0
US threat of more tariffs on China hits yuan, Aussie

2018-07-11 theedgemarkets
LONDON (July 11): The Chinese yuan skidded towards an 11-month low and the Australian dollar fell on Wednesday after the Trump administration threatened 10 percent tariffs on $200 billion worth of Chinese imports in an escalating trade conflict.
SCGLF SCGLY GLE

0
U.S. threat of more tariffs on China hits yuan, Aussie

2018-07-11 reuters
LONDON (Reuters) - The Chinese yuan skidded towards an 11-month low and the Australian dollar fell on Wednesday after the Trump administration threatened 10 percent tariffs on $200 billion worth of Chinese imports in an escalating trade conflict.
SCGLF SCGLY GLE

0
Yuan, Aussie hit as US threatens more tariffs on China

2018-07-11 thehindubusinessline
The dollar rose near an 11-month high against the Chinese yuan and the Australian dollar tumbled after the US said it would slap tariffs on an extra $200 billion of imports from China, sharply escalating tensions between the world's two biggest economies.
SCGLF SCGLY GLE

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: F849BQAA2